|
International Drug and Explosive Detection Firm IDenta Corp. Announces Five New Patent Applications -- Company's R&D Developing New Products That Will Generate Significant New Revenues
(Marketwire Via Acquire Media NewsEdge) JERUSALEM, November 10 / MARKET WIRE/ --
IDenta Corp. (PINKSHEETS: IDTA) announced today
that it is completing the submission of five new international patent
applications for its drug precursor and explosive detection products. The
new patents will add to the company's four existing patents for cocaine and
crack detection, heroin detection, ecstasy detection and its patent for
chemical detection product packaging.
"These new patents will add significant book value to the company's
assets," asserted Yaacov Shoham, IDTA CEO. "Each new product addresses
either a critical new need, such as drug precursors, or is an important
refinement to existing drug detection products. There is great demand for
each of these new IDenta products, and we believe that in the coming years
they will add significant revenue and profits to our bottom line."
"IDenta's continued research and development team," Shoham continued, "is
unique in this industry. Most companies have simply continued to package
the same chemical detectors for many years without further investigation
and refinement. They have a small or no R&D department. IDenta continues to
not only make improvements because of our dedicated R&D team, but we are
creating products that correct mistakes found in previously accepted
chemistry, such as our new ephedrine detectors."
The new IDenta chemical detection patents will be for:
1. Gamma hydroxybutyrate -- GHB. This illicit drug is colorless and
odorless and is often referred to as the "date rape drug."
2. Triacetone Triperoxide -- TATP. This is an explosive substance made from
acetone, peroxide and other easily obtainable ingredients. TATP is
extremely dangerous and is commonly used in terrorist attacks in the Middle
East.
3. Ephedrine -- known primarily as one of the most dangerous of dietary
supplements, this dangerous chemical is also a critical ingredient used in
the production of methamphetamine. IDenta is applying for a patent for both
drug detection and precursor detection.
4. Acetic anhydride is a clear, colorless liquid with a very pungent,
penetrating, vinegar-like odor that combines with water to form acetic
acid. The IDenta patent will be for this precursor chemical used in the
production of heroin.
5. Marijuana fast blue BB -- IDenta is applying for a drug detector
patent.
"Many of drug detection products on the market today are presumptive not
precise," asserted IDTA CEO Yaacov Shoham. "That will never be the case
with any IDenta product. Each product we patent and produce for sale will
always be easy to use, provide instant results and yield no false
positives. When IDenta drug, precursor and explosive detection products
change colors you can be assured that you have positively identified the
substance in question."
ABOUT IDENTA
Since 2003, IDenta Corporation has been recognized as a worldwide leader in
the development of proprietary on-site drug, drug precursor and explosive
detection kits. IDenta develops, manufactures and distributes products for
the both professional and civil markets which consistently pass the highest
qualifications and testing procedures of law enforcement and security
agencies around the world.
Accutest? IDenta products are being promoted through major Law
Enforcement trade journals, such as The Law Enforcement Technology
Magazine, Law Officer Magazine, American Probation and Parole Journal, the
NarcOfficer magazine and Police Magazine. Both companies and their
representatives are also participating in numerous industry trade shows.
Accutest? IDenta is also a nominee for the 2008 Forensics Innovation
Awards by the Cygnus Law Enforcement Group.
Information concerning IDenta's entire product line may be found at
www.IDenta.biz. and www.accutest.net.
DISCLAIMER
Certain of the statements contained herein may be, within the meaning of
the federal securities laws, "forward-looking statements" that are subject
to risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements. Such
forward-looking statements involve known and unknown risks, uncertainties
and other factors which may cause the actual results, performance or
achievements of the company to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. These forward-looking statements are based on
management's expectations as of the date hereof, and the company does not
undertake any responsibility to update any of these statements in the
future.
For Investor Relations, lobbying interests or information concerning
IDenta's products internationally or the development of new chemical
detectors, contact: Yaacov Shoham, IDenta Corp., CEO, Tel: +972-52-6554487,
fpi@drugsdetector.com. www.identa.biz
For Investor Relations in the US, contact: Randy Jacobs, Corporate
Spokesman, IDentaNews@sitcomllc.com, 1-800-316-9437.
For information about the Accutest? - IDenta products in the US, please
contact: Mr. Eyal Golan, COO, JANT PHARMACAL CORPORATION, 16255 Ventura
Blvd. #505, Encino, CA 91436, Toll Free: 800-676-5565, 661-478-0582
(mobile), golan@accutest.net, www.accutestidenta.net.
Contact:
Yaacov Shoham
IDenta Corp.
CEO
Tel: +972-52-6554487fpi@drugsdetector.comhttp://www.identa.biz
Copyright ? 2008 Marketwire
[ Back To TMCnet.com's Homepage ]
|
INDUSTRIES
Activate Email 
INDUSTRIES
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO West, September 1-3, 2009. Los Angeles, CA.
